SCHEMBL20036033

SCHEMBL20036033

COc1ccccc1N1CCN(C(=O)c2ccc(NS(=O)(=O)c3c(Cl)cc(Br)cc3Cl)cc2)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.67
▸ PKM P14618 4/20 0.67
▸ MAPT P10636 3/20 0.67
▸ HTT P42858 2/20 0.67
▸ LMNA P02545 5/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ TSHR P16473 2/20 0.56
▸ RECQL P46063 1/20 0.55
▸ MEN1 O00255 2/20 0.55
▸ POLB P06746 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ NAMPT P43490 1/20 0.55
▸ HCRTR1 O43613 1/20 0.54
▸ NPSR1 Q6W5P4 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ GLA P06280 1/20 0.53
▸ REV1 Q9UBZ9 1/20 0.52
▸ USP2 O75604 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20035975 0.89 ALDH1A1 (0.64) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL20036050 0.85 ALDH1A1 (0.69) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL2703446 0.84 PKM (0.87) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL17696042 0.84 ALDH1A1 (0.65) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL20035974 0.84 ALDH1A1 (0.67) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL2703575 0.83 PKM (0.71) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL20036040 0.83 ALDH1A1 (0.66) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL20035973 0.83 ALDH1A1 (0.68) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL20036032 0.83 ALDH1A1 (0.66) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL2703016 0.83 ALDH1A1 (0.86) ALDH1A1PKMMAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3406251-B1 PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY AGIOS PHARMACEUTICALS INC (US) 2023-11-29 — — EP disclosed
EP-2704721-B1 PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY AGIOS PHARMACEUTICALS INC (US) 2018-04-11 — — EP disclosed
Send feedback